Human papillomavirus (HPV) infections are associated with acute and recurrent disease in sexually active individuals and with squamous cell carcinomas in the female and male genital tracts. In addition, the viruses may be transmitted from an infected mother to her offspring at (or before) birth and cause respiratory papillomatosis in the child. The proposed investigations will determine the outcome of initially asymptomatic HPV infections, assess virus prevalence and virus activation during pregnancy, examine virologically the events at birth to understand mother to offspring transmission, evaluate the role of HPVs in the etiology of cervical adenocarcinoma, ovarian tumors and other genital tract pathologies and examine the role of HPVs as risk factors in squamous cell carcinoma of the cervix. Diagnosis of HPV will be made by dot blot, Southern and in situ hybridization assays. In addition, the technique of gene amplication by polymerase chain reaction will be established in the laboratory and utilized as a means of HPV diagnosis. Virus-excreting asymptomatic women attending the Baltimore City STD clinics will be monitored prospectively for virus prevalence, virus type and the development of cytologic and clinical abnormalities. Women attending the Obstetrics Clinic of Johns Hopkins Hospital will be monitored for HPV prevalence during pregnancy beginning with their first visit to the Clinic. At the time of delivery, exfoliated cervical cells from the mother, respiratory secretions of the neonate, placenta, amnion and amniotic fluid will be assayed for presence of HPV. Fresh specimens and pathological material collected at the Johns Hopkins Hospital will be investigated for the presence, localization and the state of the HPV genome. About 3,000 specimens collected in two WHO case-control studies of cervical cancer will be examined for HPV type, amount of virus and frequency of viral integration. The results of these investigations will clarify some aspects of the biology of HPV infections and assist in evaluation of the role of HPvs in the etiology of lower genital tract cancers.

Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Thomas, D L; Zenilman, J M; Alter, H J et al. (1995) Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. J Infect Dis 171:768-75
Thomas, D L; Rompalo, A M; Zenilman, J et al. (1994) Association of hepatitis C virus infection with false-positive tests for syphilis. J Infect Dis 170:1579-81
West, S; Munoz, B; Bobo, L et al. (1993) Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Invest Ophthalmol Vis Sci 34:3194-8
Kessis, T D; Slebos, R J; Han, S M et al. (1993) p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 143:1398-405
Kessis, T D; Slebos, R J; Nelson, W G et al. (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A 90:3988-92
Guerrero, E; Daniel, R W; Bosch, F X et al. (1992) Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 30:2951-9
Hermonat, P L; Daniel, R W; Shah, K V (1992) The spermicide nonoxynol-9 does not inactivate papillomavirus. Sex Transm Dis 19:203-5
Coutlee, F; Bobo, L; Abbass, H et al. (1992) Detection of HPV-16 in cell lines and cervical lavage specimens by a polymerase chain reaction-enzyme immunoassay assay. J Med Virol 37:22-9
Upchurch, D M; Ray, P; Reichart, C et al. (1992) Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic. Sex Transm Dis 19:175-80
Muller, M; Viscidi, R P; Sun, Y et al. (1992) Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 187:508-14

Showing the most recent 10 out of 58 publications